MyoKardia

MyoKardia is pioneering a precision medicine approach to discover, develop and commercialize targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.
Company Growth (employees)
Type
Public
HQ
South San Francisco, US
Size (employees)
98 (est)
MyoKardia is headquartered in South San Francisco, US

Key People/Management at MyoKardia

Tassos Gianakakos

Tassos Gianakakos

CEO
Robert McDowell

Robert McDowell

Vice President, Drug Discovery

MyoKardia Office Locations

MyoKardia has an office in South San Francisco
South San Francisco, US (HQ)
333 Allerton Ave

MyoKardia Financials and Metrics

MyoKardia Financials

MyoKardia's revenue was reported to be $39.2 m in FY, 2016
USD

Revenue (Q3, 2017)

5.6 m

Net income (Q3, 2017)

(14.2 m)

EBIT (Q3, 2017)

(14.6 m)

Market capitalization (13-Dec-2017)

1.2 b

Cash (30-Sep-2017)

227.2 m
MyoKardia's current market capitalization is $1.2 b.
USDFY, 2015FY, 2016

Revenue

14.2 m39.2 m

Revenue growth, %

176%

R&D expense

28.4 m36.2 m

General and administrative expense

9 m16.3 m
USDQ1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

3.6 m3.5 m3.6 m5.6 m5.6 m5.6 m

R&D expense

8.1 m9.3 m8.8 m11.9 m13.7 m14.4 m

General and administrative expense

3.9 m4.1 m4 m5.5 m5.1 m5.9 m

Operating expense total

12 m13.3 m12.8 m17.4 m18.8 m20.2 m
USDFY, 2015FY, 2016

Cash

112.3 m135.8 m

Accounts Receivable

45 m

Prepaid Expenses

1.3 m1.4 m

Current Assets

113.5 m186.3 m
USDQ1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

99.5 m87.6 m77.1 m135.6 m117.3 m227.2 m

Prepaid Expenses

1.2 m1.1 m762 k1.8 m1.2 m1.5 m

Current Assets

100.7 m88.7 m77.9 m149.4 m134.6 m248.7 m

PP&E

3 m2.9 m2.7 m2.6 m2.9 m2.6 m
USDFY, 2015FY, 2016

Net Income

(22.9 m)(13.2 m)

Depreciation and Amortization

965 k1.1 m

Accounts Receivable

(45 m)

Accounts Payable

1.3 m(434 k)
USDQ1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

(8.4 m)(18.2 m)(27.4 m)(11.5 m)(24.4 m)(38.6 m)

Depreciation and Amortization

256 k531 k815 k316 k634 k977 k

Accounts Receivable

45 m45 m45 m

Accounts Payable

(115 k)(436 k)(372 k)629 k(488 k)228 k
USDY, 2017

Revenue/Employee

57.4 k

Financial Leverage

1.2 x
Show all financial metrics

MyoKardia Operating Metrics

FY, 2015FY, 2016

Patents (US)

23

Patents Pending (US)

77

Patents Pending (foreign)

3430
Show all operating metrics

MyoKardia Market Value History

MyoKardia's Web-traffic and Trends

MyoKardia Online and Social Media Presence

MyoKardia Company Life and Culture

You may also be interested in